Nephro-protective effect of Kangqianling decoction on chronic renal failure rats

Journal of Ethnopharmacology

Volumn 122, Issue 2, 2009, Pages 367-373

  He, Liqun ^a   Shen, Peicheng ^a   Fu, Qiang ^b   Li, Jun ^c   Dan, Mo ^d   Wang, Xiaoyan ^d   Jia, Wei ^d  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

^c Zhuhai City NO 5 Hospital   (China)

^d Chinese National Human Genome Center at Shanghai   (China)

Author keywords

5 6 renal ablation; Chronic renal failure; Kangqianling decoction; Renal fibrosis

Indexed keywords

ANGELICA SINENSIS EXTRACT; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; BADIX ACHYRANTHIS BIDENTATAE EXTRACT; CHINESE DRUG; CREATININE; FRUCTUS JUJUBAE EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KANGQIANLING; MESSENGER RNA; PLANT EXTRACT; SALVIA MILTIORRHIZA EXTRACT; SEMEN PERWICAE EXTRACT; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; SYSTOLIC BLOOD PRESSURE; UREMIA;

ANGELICA SINENSIS; ANGIOSPERMS; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BLOOD UREA NITROGEN; CREATININE; DRUGS, CHINESE HERBAL; KIDNEY; KIDNEY FAILURE, CHRONIC; NF-KAPPA B; PROTEINS; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, MESSENGER; SALVIA MILTIORRHIZA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; ZIZIPHUS;

RATTUS;

EID: 60849091897     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.12.018     Document Type: Article

References (26)

1. Allison A.E. Molecular basis of renal fibrosis. Pediatric Nephrology 15 (2000) 290-301
2. Barnes P.J., and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. New England Journal of Medicine 336 (1997) 1066-1071
3. Chen Z.P., and He L.Q. Clinical study on the effects of "Kangqianling Granule" on bone metabolism in chronic renal failure patients. Journal of Shanghai TCM 40 (2006) 34-35
4. Fujihara C.K., Antunes G.R., Mattar A.L., Andreoli N., Malheiros D.M., Noronha I.L., and Zatz R. Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney. Kidney International 64 (2003) 2172-2181
5. Gaedeke J., Peters H., Noble N.A., and Border W.A. Angiotensin II, TGF-beta and renal fibrosis. Contribution Nephrology 135 (2001) 153-160
6. Goncalves A.R.R., Fujihara C.K., Mattar A.L., Malheiros D.M.A.C., Noronha I.D.L., De Nucci G., and Zatz R. Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory. American Journal of Physiology-Renal Physiology 286 (2004) F945-F954
7. Guijarro C., and Egido J. Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney International 59 (2001) 415-424
8. Guo Q.Y. Curative effect observation of hypertension nephropathy with modified Shengqidihuang decoction and Taohongsiwu decoction. Journal of Henan University of Chinese Medicine 21 (2006) 28-32
9. Hannedouche T., Chauveau P., Kalou F., Albouze G., Lacour B., and Jungers P. Factors affecting progression in advanced chronic renal failure. Clinical Nephrology 39 (1993) 312-320
10. He L.Q., and Cai G. The clinical observation of the JIAN-PI-QIN-HUI prescription on spleen deficiency and dampness heat style patients with chronic renal failure. Journal of International Medical Science of China 14 (2005) 270-274
11. He L.Q., Li J., and Li Y. The effect of "FUZHENGHUOXUE decoction" on the expressions of fibronectin and transforming growth factor-βmRNA in renal tissue of the CRF rats. Journal of Chinese Medicine 46 (2005) 454-457
12. He L.Q., Wang Y., Cao H.X., and Li J. The effect of kangQianling decoction on PDGF-mRNA, TNFα-mRNA expression of CRF rat renal tissue. Journal of China Experiments the Square to Learn 9 (2003) 29-32
13. Houlihan C.A., Akdeniz A., Tsalamandris C., Cooper M.E., Jerums G., and Gilbert R.E. Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction. Diabetes Care 25 (2002) 1072-1077
14. Jin Y.M., Zhu R., Zhang C.S., Li M., Deng Y.Y., and Shen L.M. Treating hematomas after renal puncture with "Taohong Siwu decoction". Journal of Shanghai Traditional Chinese Medicine 40 (2006) 30-32
15. Karkar A.M., Koshino Y., Cashman S.J., Dash A.C., Bonnefoy J., Meager A., and Rees A.J. Passive immunization against TNF alpha and IL-1B protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats. Clinical and Experimental Immunology 90 (1992) 312-318
16. Lee L.K., Meyer T.W., Pollock A.S., and Lovett D.H. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. Journal of Clinical Investigation 96 (1995) 953-964
17. Li J., He L.Q., Li Y., and Hou W.G. The effect of kang qian ling 2 decoction on serum lipid metabolism of chronic renal fail rats. Journal of International Medical Science of China 3 (2003) 204-206
18. Muller D.N., Dechend R., Mervaala E.M., Park J.K., Schmidt F., Fiebeler A., Theuer J., Breu V., Ganten D., Haller H., and Luft F.C. NF-κB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 35 (2000) 193-201
19. Ng Y.Y., Huang T.P., Yang W.C., Chen Z.P., Yang A.H., Mu W., Nikolic-Paterson D.J., Atkins R.C., and Lan H.Y. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney International 54 (1998) 864-876
20. Noronha I.L., Fujihara C.K., and Zatz R. The inflammatory component inprogressive renal disease-are interventions possible (Abstract)?. Nephrology Dial Transplant 17 (2002) 363
21. Ruiz-Ortega M., and Egido J. Angiotensin II modulates cell growthrelated events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney International 52 (1997) 1497-1510
22. Rumble J.R., Gilbert R.E., Cox A., Wu L., and Cooper M.E. Angiotensin converting enzyme inhibition reduces the expression of transforming growth factor-beta(1) and type IV collagen in diabetic vasculopathy. Journal of Hypertension 16 (1998) 1603-1609
23. Tipping P.G., Kitching A.R., Cunningham M.A., and Holdsworth S.R. Immunopathogenesis of crescentic glomerulonephritis. Current Opinion Nephrology Hypertension 8 (1999) 281-286
24. Weistuch J.M., and Dworkin L.D. Does essential hypertension cause end-stage renal disease?. Kidney International 41 (1992) S33-S37
25. Wolf G., Ziyadeh F.N., and Stahl R.A. Angiotensin II stimulates expression of transforming growth factor beta receptor type II in cultured mouse proximal tubular cells. Journal of Molecular Medicine 77 (1999) 556-564
26. Xia Y.B., Lu G.Y., Xiong P.H., Xie Y., and Shen L. Plasma concentration changes and the clinical significance of plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with chronical glomerulonephritic and the intervenient research on them. Journal of Suzhou University 27 (2007) 105-107